CRVS

NasdaqGMHealthcare

Corvus Pharmaceuticals, Inc.

Latest filing · 2026-05-18 · scanner 8d behind

$12.87

+2.1%· 24h

Score

/ 100

Active candidate

4 triggers firing

C-suite buyFirst buy 12moHigh short int.Days to cover

Market cap

$1081.40M

Float

72.8M

87% of total

Shares out

84,090,424

Short % float

••••

Pro only

Days to cover

••••

Pro only

Price

2 buys

CRVS

$12.87

$5.39 · -29.5%

AI briefPro — synthesised analysis of insider signals and filing context.

Upgrade →

Rule breakdown50 / 110 pts max

45% of maximum scoreSignalContext

Form 4 signals

Cluster buy

3+ distinct insiders with open-market buys in the last 30 days

–

pts

C-suite buy

CEO, CFO, Chair, or President made an open-market purchase

MILLER RICHARD A MD — President and CEO

+20

pts

Large single buy

One open-market purchase exceeded the dollar threshold

–

pts

First buy in 12 months

An insider bought for the first time in the trailing 12 months

MILLER RICHARD A MD

+15

pts

Net buying (90d)

Net (buys − sells) USD over the last 90 days is positive

–

pts

Context amplifiers

High short interest

Short interest as % of float exceeds the squeeze threshold

24.9% of float

+10

pts

Small float

Float is below the threshold — amplifies any accumulation signal

–

pts

High days-to-cover

DTC > threshold — shorts can't exit cleanly on a squeeze

14.9d to cover

pts

Volume spike

Most-recent day's volume was >2× the 20-day average

–

pts

Type	Date	Insider	Title	Shares	Price	Value
Buy	2026-05-18	MILLER RICHARD A MD	President and CEO	5,000	$12.05	$60.3K
Buy	2026-05-18	MILLER RICHARD A MD	President and CEO	1,932	$12.01	$23.2K